▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

Intel Q3 22 Earnings Conference Call At 5:00 PM ET

By RTTNews Staff Writer ✉ | Published: 10/27/2022 6:00 AM ET

Intel Corporation (INTC) will host a conference call at 5:00 PM ET on October 27, 2022, to discuss Q3 22 earnings results.

To access the live webcast, log on to https://www.intc.com/news-events/ir-calendar/detail/20221027-q3-2022-intel-corporation-earnings-conference-call

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In February 2023

Biotech Stocks Facing FDA Decision In February 2023

Biotech stocks Facing FDA Decision in January 2023

Biotech stocks Facing FDA Decision in January 2023

Biotech Stocks Facing FDA Decision In December 2022

Biotech Stocks Facing FDA Decision In December 2022

Latest Updates on COVID-19

Covid-19 Remains An International Emergency: WHO

FDA Advisors Propose To Replace Primary COVID Shots With New Bivalent Shots

U.S. Covid Metrics Signal Ease In Pandemic

US Covid Deaths Rise By 78% In 2 Weeks

78% Increase In US Covid Deaths In A Fortnight

Read More

COVID-19: Drugs in Development

RELATED NEWS

Intel Corporation Q4 Earnings Summary

Intel Q4 22 Earnings Conference Call At 5:00 PM ET

Follow RTT

Editor's Pick
Most Read
Most Emailed

Titans Global Recalls Certain JSJ Cakes

Google Unveils Conversational AI Service Bard

DuPont Q4 Results Miss Estimates; Boosts Dividend 9%

Boeing To Cut About 2000 Finance, HR Jobs In 2023

Fresh Ideation Recalls Sandwiches And Other Products

FSIS Warns Against Ready-To-Eat Stuffed Chicken Product

FSIS Warns Against Wegmans Chicken Korma With Basmati Turmeric Rice

Daiso Recalls Certain Prepackaged Snacks

Children's Robes, Pajamas Recalled On Burn Risks

China's Xpeng Launches Two Smart EVs For Europe

Shop Me Ca Recalls Diep Bao Cream For Lead Concerns

CVS Health Nears Deal To Acquire Oak Street Health For About $10.5 Bln : Report

Regeneron Pharmaceuticals Q4 Profit Declines

Personalis, Moderna Continue Partnership On Personalized Cancer Vaccine Program

Gracell Biotechnologies: FDA Clears IND Application Of GC012F

Gilead Sciences : FDA Approves Trodelvy In Pre-treated HR+/HER2- Metastatic Breast Cancer

Twist Bioscience Corp Q1 Loss decreases, beats estimates

Merck's KEYTRUDA Plus Chemotherapy Meets Primary Goal As First-Line Therapy In Endometrial Carcinoma

Regeneron Pharma Q4 Profit Declines; Adj. Total Revenues Up 14%

AstraZeneca: European Commission Approves Forxiga In Treatment Of Symptomatic Chronic Heart Failure

Zimmer Biomet Sees FY23 Profit In Line With View

FDA Okays Boston Scientific's LithoVue Elite Single-Use Digital Flexible Ureteroscope System

Cigna Corp. Q4 Profit Increases, beats estimates

Equinor Q4 Profit More Than Doubles; To Repurchase Up To $6 Billion Of Shares

Take-Two Interactive Software Inc Q3 Earnings Summary

Vishay Intertechnology Guides Q1 Revenues In Line With Estimates - Update

Crown Holdings Inc. Q4 Earnings Summary

Genworth Financial Inc. Q4 Profit Increases, beats estimates

ON Semiconductor Guides Q1 Well Below Estimates; Approves $3 Bln Share Buyback - Update

Maximus Inc Reports Retreat In Q1 Profit, misses estimates

Bed Bath & Beyond Plans To Raise About $1 Bln To Avoid Bankruptcy

STERIS plc Q3 Profit Decreases, misses estimates

Black Hills Corp Q4 Profit misses estimates

Timken Guides FY23 In Line With View; Q4 Adj. EPS Tops Estimates

TTM Technologies Q4 Profit Decreases, but beats estimates